Probiotics May Reduce Chemotherapy Side Effects in Breast Cancer Patients
Emerging research suggests that multi-strain probiotics may help reduce common chemotherapy side effects such as fatigue and nausea in breast cancer patients, improving quality of life during treatment.
Chemotherapy remains a cornerstone in breast cancer treatment, renowned for its effectiveness in combating cancer cells. However, it also comes with significant side effects, including fatigue, weakness, and heightened vulnerability to infections, which can impact patients' quality of life and treatment adherence. Recent research highlights the potential role of probiotics as a supportive supplement during chemotherapy.
A study published in the open-access journal Pharmacia investigated the impact of multi-strain probiotics on chemotherapy-related side effects in breast cancer patients. The study tracked improvements in symptoms such as fatigue and nausea, showing that probiotic supplementation—comprising seven different bacterial strains—could alleviate these common adverse effects both before and after treatment.
In addition to symptom relief, the research found that probiotics helped improve blood urea nitrogen levels, which are linked to kidney function and overall metabolic health. Patients also experienced greater independence in their daily activities, likely due to reduced fatigue and nausea. These findings suggest that certain probiotic strains may support immune function and overall well-being during intensive cancer therapies.
Despite promising results, researchers emphasize the need for larger-scale studies to confirm these benefits and determine the most effective probiotic formulations. Incorporating probiotics into standard cancer care could, in the future, offer a safe and accessible way to mitigate side effects and enhance patient quality of life during chemotherapy.
Source: https://medicalxpress.com/news/2025-05-probiotic-supplementation-chemotherapy-side-effects.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Repurposing Asthma Medication for Treating Rare Neurological Disorder ADCY5-Related Dyskinesia
Research indicates that the asthma medication theophylline may help manage symptoms of ADCY5-related dyskinesia, a rare neurological disorder, offering hope for improved patient quality of life.
Local Community-Led Approaches Enhance Health Support for Rural Australian Children
Community-driven, place-based health strategies are transforming access to vital services for children in Australia's rural areas, ensuring better developmental outcomes through local partnerships and tailored solutions.
Study Finds No Significant Difference in Dementia Risk Between GLP-1 RAs and DPP4 Inhibitors in Older Adults with Type 2 Diabetes
A recent study shows no significant difference in dementia risk among older adults with type 2 diabetes taking GLP-1 RAs or DPP4 inhibitors, highlighting the need for personalized treatment decisions.
Government Termination of Trans Health Research Sparks Concerns Across Science and Society
The abrupt termination of a pivotal trans health research study by the government raises concerns over scientific progress and societal impacts, highlighting risks to community trust and health equity.